30th Annual Perspectives in Urology: Point Counterpoint

Coronado Island Marriott, San Diego, California
November 2022

innovations in urologic practice logo

Overview

The 30th Annual Perspectives in Urology: Point Counterpoint (PCP 30) will bring together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in men’s health, general urology, and genitourinary cancers. This annual interactive conference will offer topical lectures, pro/con debates, interesting-case presentations, interactive panel discussions, and interactive audience response technology. Topics include LUTS, localized and advanced prostate cancer, bladder cancer and immunotherapy, upper tract cancer management, renal cell carcinoma, MRI and imaging, and other urologic topics.

The goal of PCP 30 is to address key questions on practice-changing developments in these topics, and to examine the next generation in diagnosis and treatment. The conference’s format includes not only didactic lectures, but also debates, point-counterpoint discussion panels, and unique-case presentations.

Program Chair

E. David Crawford, MD

E. David Crawford, MD

Professor of Urology
University of California, San Diego
La Jolla, CA

Debates from Urology and Medical Oncology Experts

Attend CME Sessions

Connect with Peers and Experts

Agenda

The 29th Annual Perspectives in Urology: Point Counterpoint (PCP 29) conference offers a robust program with multi-track sessions, debates, discussion panels, and more. Join us November 18-20, 2021, in sunny San Diego, California.

Thursday, November 18, 2021

11:00am – 1:00pm

Registration

12:00pm – 1:00pm

Industry-supported Lunch Program
Focus on UTUC
Speaker: TBD
Supported by UroGen Pharma

1:00pm – 6:30pm

Exhibits Open

1:00pm – 1:10pm

Welcome and Introduction
E. David Crawford, MD

1:10pm – 2:40pm 

SESSION I: UROLOGIC PRACTICE
Moderator: E. David Crawford, MD

1:10pm – 1:20pm

LUTS: Latest in Prevention, Clinical Trials, and Approved Treatments
Michael E. Albo, MD

1:20pm – 1:30pm

Treating BPH: Comparing Treatment Modalities
Michael E. Albo, MD

1:30pm – 1:40pm

The Genitourinary Microbiome and UTI: How a Better Understanding of the Urobiome Influences Understanding of UTI
A. Lenore Ackerman, MD, PhD.

1:40pm – 1:50pm

How to Optimize a Telehealth Visit (pre-recorded)
Evan R. Goldfischer, MD, MBA

1:50pm – 2:10pm

Panel Discussion

2:10pm – 2:20pm

Update on the California Legislative Agenda and its Impact on the Practice of Medicine
Edward S. Cohen, MD

2:20pm – 2:30pm

Private Equity and Value-Based Care: Is There a Future?
Edward S. Cohen, MD

2:30pm – 2:35pm

Practice Tips 1 (pre-recorded)
Neil H. Baum, MD

2:35pm – 2:40pm

Practice Tips 2 (pre-recorded)
Neil H. Baum, MD

2:40pm – 4:10pm

SESSION II: BLADDER/UPPER TRACT CANCERS
Moderator: Amirali Salmasi, MD

2:40pm – 2:50pm

Emerging Treatments for BCG Unresponsive Non-muscle Invasive Bladder Cancer
Amirali Salmasi, MD

2:50pm – 3:00pm

Updating the Definitions, Endpoints, and Clinical Trial Designs for Bladder Cancer
Amirali Salmasi, MD

3:00pm – 3:10pm

Upper Tract Urothelial Cancer: What You Need to Know
Ithaar H. Derweesh, MD

3:10pm – 3:30pm

Panel Discussion

3:30pm – 3:50pm

Renal Mass-Localized Renal Cancer Evaluation (2 parts, pre-recorded)
Steven C. Campbell, MD, PhD

3:50pm – 4:10pm

Point-Counterpoint: Neoadjuvant Chemotherapy Prior to Cystectomy 
Pro: Amirali Salmasi, MD
Con: Alan H. Bryce, MD

4:10pm – 4:30pm

Break and Visit Exhibits

4:30pm – 5:30pm

SESSION III: PROSTATE CANCER EARLY DIAGNOSIS & THERAPY
Moderator: E. David Crawford, MD

4:30pm – 4:40pm

The USPSTF Prostate Cancer Screening Recommendations: A Pathway Forward for Early Detection in 2021
E. David Crawford, MD

4:40pm – 4:50pm

Prostate Cancer Screening & Genetic Testing: The NCCN Guidelines
Christopher J. Kane, MD

4:50pm – 5:10pm

Panel Discussion

5:10pm – 5:30pm

Point-Counterpoint: Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines?
Pro: Rana R. McKay, MD
Con: E. David Crawford, MD

5:30pm – 5:50pm

Break and Visit Exhibits

5:50pm – 6:30pm

SESSION V: SURGICAL APPROACHES TO UROLOGIC DISORDERS
Moderator: Manoj J. Monga, MD

5:50pm – 6:00pm

Asymptomatic Stones: Treat or Observe?
Manoj J. Monga, MD   

6:00pm – 6:10pm

Mini PCNL vs. Standard PCNL
Manoj J. Monga, MD

6:10pm – 6:30pm

Panel Discussion

6:30pm – 7:30pm

Welcome Reception in Exhibit Hall

Evening

On Own

Friday, November 19, 2021

7:00am – 12:00pm

Exhibits Open

7:00am – 8:00am

Industry-supported Breakfast Program
ERLEADA: For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
Speakers: Matthew B. Rettig, MD and Steven E. Finkelstein, MD
Supported by Janssen Biotech

8:00am – 9:40am

SESSION IV: FOCAL THERAPY AND IMAGING FOR PROSTATE CANCER
Moderator: E. David Crawford, MD

8:00am – 8:10am

Accuracy of ExactVu™ Micro-Ultrasound for Diagnosis of Prostate Cancer
Priya N. Werahera, PhD

8:10am – 8:20am

High Resolution Micro-Ultrasound for PCa Detection
and Surveillance (pre-recorded)
Laurence Klotz, MD, FRCSC

8:20am – 8:30am

29 MHz High Resolution Micro-Ultrasound: Improving Real-Time Targeting of Prostate Biopsies
E. David Crawford, MD

8:30am – 8:40am

High Intensity Focused Ultrasound for Prostate Cancer (pre-recorded)
Hao G. Nguyen, MD, PhD

8:40am – 9:10am

Panel Discussion

9:10am – 9:30am

Point-Counterpoint: Is MRI Fusion Biopsy the New Gold Standard of Diagnosis?
Pro: A. Karim Kader, MD, PhD (pre-recorded)
Con: Priya N. Werahera, PhD

9:30am – 9:50am

Point-Counterpoint: It Is Time to Abandon Transrectal Prostate Biopsy for Perineal Prostate Biopsy?
Pro: Paul B. Arangua, MPH
Con: Michael E. Albo, MD

9:50am – 10:10am

Panel Discussion

10:10am – 10:30am

Break and Visit Exhibits

10:30am – 11:15am

Industry-supported Program
Title TBD
Speaker: TBD
Supported by Amgen

11:15am – 12:00pm

SESSION VI: Breaking News
Moderator: E. David Crawford, MD

12:00pm – 1:00pm

Industry-supported Lunch Program
Important Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment LandscapeSpeaker: Edward M. Uchio, MD, FACS, CPI

Supported by Astellas Pharma US and Pfizer Oncology

Afternoon and Evening

On Own

Saturday, November 20, 2021

7:00am – 10:30am

Exhibits Open

7:00am – 8:00am

Industry Breakfast Symposium – TBD
NUBEQA® (darolutamide) in Non-Metastatic CRPC: A Clinical Review of the Efficacy and Tolerability of NUBEQA as a First-Line Option in Non-Metastatic CRPC
Speaker: Neal D. Shore, MD
Supported by Bayer Oncology

8:00am – 10:00am

SESSION VII: PROSTATE CANCER
Moderator: Alan H. Bryce, MD

8:00am – 8:10am

Genetic Testing and Next Generation DNA Sequencing
Alan H. Bryce, MD

8:10am – 8:30am

Point-Counterpoint: There is a Role for Currently Available Biomarkers/Genomics in the Risk Stratification of Prostate Cancer
Pro: E. David Crawford, MD
Con: Alan H. Bryce, MD

8:30am – 8:40am

Updates in Treatment Using ADT and Anti-Androgens
E. David Crawford, MD

8:40am – 9:00am

Point-Counterpoint: Management of mCRPC
Pro: Rana R. McKay, MD
Con: Alan H. Bryce, MD

9:00am – 9:10am

Immunotherapeutic Advances for mCRPC: PARP Inhibitors
Christopher J. Kane, MD

9:10am – 9:30am

Panel Discussion

9:30am – 10:00am

Break and Visit Exhibits

10:00am – 10:10am

Current Status of PSMA PET in the United States
Phillip J. Koo, MD

10:10am – 10:20am

PSMA Targeted Therapies and the Role of the Urologist
Phillip J. Koo, MD

10:20am – 10:30am

nmCRPC: Is Navigating the M0 Space the Next Moon Shot?
E. David Crawford, MD

10:40am – 11:00am

Panel Discussion

11:00am – 11:50am

Industry Lunch Symposium
Introducing an Oral Treatment Option for Advanced Prostate Cancer
Speaker: Jeffrey Frankel, MD
Supported by Myovant Sciences

11:50am – 12:00pm

Closing Remarks
E. David Crawford, MD

Accommodations & Transportation

Coronado Island Marriott
2000 Second Street
Coronado, CA

Whether you are in town for an event or a waterfront getaway, Coronado Island Marriott Resort & Spa offers an idyllic retreat. With views of the San Diego skyline and Coronado Bridge, the hotel is ideally situated to provide easy access to Coronado Beach and San Diego attractions, including the Gaslamp District and Balboa Park. Inside, guests can recharge in spacious, redesigned hotel rooms, suites, and private cottages. The resort boasts three pools, a pickleball court, a newly renovated wellness center and a day spa, as well as delicious dining options.

ROOM RESERVATIONS:
https://www.marriott.com/hotels/travel/sanci-coronado-island-marriott-resort-and-spa/

ROOM RATES:

Check with the hotel for cost and availability.

For information about activities in San Diego, see this page from the Coronado Island Marriott Lake: https://www.marriott.com/hotels/local-things-to-do/sanci-coronado-island-marriott-resort-and-spa/

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

Invited Faculty

PROGRAM DIRECTOR

E. David Crawford, MD

Professor of Urology
University of California, San Diego
La Jolla, California
A. Lenore Ackerman, MD, PhD

A. Lenore Ackerman, MD, PhD

Assistant Professor, Urology
University of California
Los Angeles, California

Michael E. Albo, MD

Michael E. Albo, MD

Vice Chair, Department of Urology
University of California, San Diego
San Diego, California

Paul B. Arangua, MPH

Paul B. Arangua, MPH

Director of Theranostics
3DBiopsy
Denver, Colorado

Neil H. Baum, MD

Neil H. Baum, MD

Virtual

Clinical Professor of Urology
Tulane University School of Medicine
New Orleans, Louisiana

Alan H. Bryce, MD

Alan H. Bryce, MD

Medical Director of the Genomic Oncology Clinic
Mayo Clinic
Scottsdale, Arizona

Steven C. Campbell, MD, PhD

Steven C. Campbell, MD, PhD

Virtual

Professor of Surgery
Program Director and Vice Chair of Urology
Chair for Urologic Oncology and Education
Glickman Urological and Kidney Institute
Cleveland Clinic
Cleveland, Ohio

Edward S. Cohen, MD

Edward S. Cohen, MD

Urologist and President
Genesis Healthcare Partners
La Jolla, California

Ithaar H. Derweesh, MD

Ithaar H. Derweesh, MD

Professor of Urology and Radiology
University of California, San Diego
San Diego, California

Evan R. Goldfischer, MD, MBA

Evan R. Goldfischer, MD, MBA

Virtual

Director of Research
Premier Medical Group
Poughkeepsie, New York

A. Karim Kader, MD, PhD

A. Karim Kader, MD, PhD

Virtual

Professor of Urology
University of California, San Diego
San Diego, California

Christopher J. Kane, MD, FACS

Christopher J. Kane, MD, FACS

Dean of Clinical Affairs, UCSD School of Medicine
CEO, UC San Diego Health Physician Group
University of California, San Diego
San Diego, California

Laurence Klotz, MD, FRCSC

Laurence Klotz, MD, FRCSC

Virtual

Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

Phillip J. Koo, MD

Phillip J. Koo, MD

Director, Chief of Diagnostic Imaging
Banner MD Anderson Cancer Center
Phoenix, Arizona

Rana R. McKay, MD (TBC)

Rana R. McKay, MD (TBC)

Associate Professor of Medicine
University of California, San Diego
San Diego, California

Manoj J. Monga, MD

Manoj J. Monga, MD

Chairman of Urology
University of California, San Diego
San Diego, California

Hao G. Nguyen MD, PhD

Hao G. Nguyen MD, PhD

Virtual

Associate Professor
Richard and Leilani Grinold Endowed Professorship in Urology
Department of Urology
University of California, San Francisco
San Francisco, California

Amirali Salmasi, MD

Amirali Salmasi, MD

Associate Professor of Urology
University of California, San Diego
San Diego, California

Priya N. Werahera, PhD

Priya N. Werahera, PhD

Research Associate Professor
University of Colorado, Denver
Aurora, Colorado

CME Information

This conference has been accredited for 11.0 AMA PRA Category 1 CreditsTM.

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Marketing Officer
Tel:434-817-2000, x193    Cell: 434-989-5508
Fax 434-817-2020    mweathersby@cjp.com

Exhibit and Sponsor Prospectus

View content from previous Perspectives in Urology: Point Counterpoint meetings